Meshalkin Research Institute of Pathology of Circulation

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Meshalkin Research Institute of Pathology of Circulation sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).

5 total trials none currently recruiting 5 completed upper quartile by trial count

Meshalkin Research Institute of Pathology of Circulation: 5 sponsored US clinical trials, none currently recruiting.

Meshalkin Research Institute of Pathology of Circulation sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 5 completed. 2 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Arterial Hypertension, with 1 trials.

Upper-quartile sponsor footprint

Meshalkin Research Institute of Pathology of Circulation sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

5 total, page 1 of 1

COMPLETED Phase 3

Renal Artery Denervation In Addition to Catheter Ablation To Eliminate Atrial Fibrillation

NCT01873352
COMPLETED Phase 2

Botulinum Toxin Injection in Epicardial Fat Pads To Treat Atrial Fibrillation After Cardiac Surgery

NCT01842529
COMPLETED Phase 2

Combined Treatment of Arterial Hypertension and Atrial Fibrillation

NCT01897545
COMPLETED Phase 2

Combined Treatment of Resistant Hypertension and Atrial Fibrillation

NCT01117025
COMPLETED Phase 3

Cryoballoon Ablation of Pulmonary Veins After Failed RF Ablation in Patients With Paroxysmal AF

NCT01611701

Phase Distribution

PhaseTrial count
Phase 2 3
Phase 3 2

Therapeutic Areas

Arterial Hypertension 1
Atrial Fibrillation 1

How the Meshalkin Research Institute of Pathology of Circulation archive is shaped

5 indexed studies, none listed as recruiting (0% open); 5 completed (100%).

Phase mix: 2 late (III/IV) vs 3 early (I/II) (balanced across stages).

Top condition: Arterial Hypertension (1 trial), 1 other listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Meshalkin Research Institute of Pathology of Circulation: archived-pipeline peers nationwide

Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Meshalkin Research Institute of Pathology of Circulation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%5%10%15%20%25% Total trials Recruiting share Meshalkin Research Institute of Pathology of Circulation4YouandMeAbbott Rapid DxAccess Business GroupAcera Surgical10xBio22nd Century Group23andMe3-C Institute for Social Development
Meshalkin Research Institute of Pathology of Circulation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Meshalkin Research Institute of Pathology of Circulation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 5 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Meshalkin Research Institute of Pathology of Circulation page

5 registered trials is a research-attention snapshot, not an endorsement of Meshalkin Research Institute of Pathology of Circulation or any single study.

  • None of Meshalkin Research Institute of Pathology of Circulation's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Arterial Hypertension is the condition Meshalkin Research Institute of Pathology of Circulation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Arterial Hypertension trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Meshalkin Research Institute of Pathology of Circulation pipeline card: 5 registered trials from official public datasets.Report a data error.